http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2322183-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_721b29679512c5ca9466b6ac40d906aa
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-064
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0091
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-00
filingDate 1999-03-17^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23e56e00d7c3112c094fde79a4af1436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0827328054c3bfbaad569bf3ea909184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3f7b7055a1a16d58f6f1db2cfc8bd8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3b5bd9525bb66e79dce5acc80de5440
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0efada0fa1614bb0857881269adec34b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40f53b4eedeaf73341979cb91b424c2a
publicationDate 1999-09-23^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2322183-A1
titleOfInvention Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
abstract The present invention is an inhalation activated inhaler (10) having a primary inhalation passage (60), a secondary inhalation passage (90) disposed in communication with the primary inhalation passage, and a source of medicament. The primary inhalation passage has inflow inhibiting mechanism connected to a blocking plate (84) positioned to selectively block fluid flow in the secondary inhalation passage. As the user's inhalation reaches a defined rate, the flow inhibiting mechanism restricts flow through the primary inhalation passage, and moves the blocking plate to enable airflow through the secondary passage. Thus, as the user achieves a desired inhalation rate, the medicament is provided through the secondary inhalation passage, thereby optimizing the delivery of medicament to the lungs.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8037880-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007115395-A1
priorityDate 1998-03-17^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11643
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1833
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID184215
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2048
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID184215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426105758

Showing number of triples: 1 to 33 of 33.